Discover how generative AI is reshaping clinical care with real-world examples, challenges, and expert advice for AI adoption ...

This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...

Q3 2025 Earnings Call Transcript October 28, 2025 Incyte Corporation beats earnings expectations. Reported EPS is $2.11, ...

Many people review their Medicare Advantage plans during the Medicare Annual Enrollment Period, hoping to find a plan that ...

Here’s what Medicare beneficiaries need to know to prepare for 2026.

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

A US-backed global gag order1 preventing governments from revealing the names of multinational corporations found shifting ...

Option Care Health Inc (OPCH) reports a robust 12% revenue increase, while navigating the impact of Stelara biosimilars and ...

Discover Ardelyx's Q3 2025 earnings highlights: record IBSRELA growth, raised revenue guidance, new pipeline expansion, and strong long-term outlook.

GoodRx reports men in D.C. fill hair-loss prescriptions over five times the national average, highlighting geographic ...

Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...